EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia



Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia



Blood 93(9): 3008-3016



To determine whether the antigen-driven T-cell response is involved in the pathogenesis of aplastic anemia (AA), we examined the complementarity-determining region 3 (CDR3) size distribution of T-cell receptor (TCR) beta-chain (BV) subfamilies in the bone marrow (BM) of untreated AA patients. AA patients who did not respond to immunosuppressive therapy and those who obtained unmaintained remission early after cyclosporine (CyA) or antithymocyte globulin (ATG) therapy exhibited essentially a normal CDR3 size pattern. In contrast, five patients who needed continuous administration of CyA to maintain remission exhibited a skewed CDR3 size pattern in a number (>40%) of BV subfamilies suggestive of clonal predominance. The skewing of CDR3 size distribution became less pronounced in one of the CyA-dependent patients when the patient achieved unmaintained remission after a 4-year therapy with CyA, whereas it persisted longer than 7 years in the other patient requiring maintenance therapy. Sequencing of BV15 cDNA for which the CDR3 size pattern exhibited apparent clonal predominance in all CyA-dependent patients showed high homology of the amino acid sequence of the CDR3 between two different patients. These findings indicate that antigen-driven expansion of T cells is involved in the pathogenesis of AA characterized by CyA-dependent recovery of hematopoiesis.

(PDF emailed within 1 workday: $29.90)

Accession: 010302411

Download citation: RISBibTeXText

PMID: 10216097



Related references

Analysis of the T-cell clonotype in the bone marrow of immune-mediated aplastic anemia Identification of a T-cell clone that preferentially proliferates in the bone marrow of a cyclosporine-dependent aplastic anemia patient. Blood 84(10 SUPPL 1): 9A, 1994

Heterogeneity in immune mechanisms of aplastic anemia The involvement of antigen-driven T-cell response is evident only in cyclosporine-dependent AA. Blood 92(10 SUPPL 1 PART 1-2): 157A, Nov 15, 1998

Lymphocyte-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity in patients with aplastic anemia: distinguishing transfusion-induced sensitization from possible immune-mediated aplastic anemia. Transplantation Proceedings 13(1 Pt 1): 245-247, 1981

Isolation of T-cell clones reactive to autologous hematopoietic cells from the bone marrow of a patient with immune-mediated aplastic anemia A CD4+TCRV-beta-21 T-cell clone lysed autologous B-lymphoblastoid cell line, probably through specific recognition of a self-antigen presented by HLA-DR. Blood 86(10 SUPPL 1): 478A, 1995

Using cyclosporine A in the treatment of partial red cell aplasia of the bone marrow and aplastic anemia. Terapevticheskii Arkhiv 64(7): 74-77, 1992

Effect of ligustrazine on CD34 antigen expression of bone marrow cells in immune-mediated aplastic anemia mice. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 18(2): 107-108, 2001

Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party. Haematologica 101(7): 884-890, 2017

Analysis of T cell receptor V-beta chain repertoire in bone marrow and peripheral blood of patients with severe aplastic anemia. British Journal of Haematology 93(SUPPL 2): 293, 1996

Session on aplastic anemia 1 european results of bone marrow transplantation for severe aplastic anemia. 1980

Session on aplastic anemia 4 bone marrow transplantation in aplastic anemia using cyclo phosphamide and total lymphoid irradiation the leiden netherlands experience. 1980

Session on aplastic anemia 2 bone marrow transplantation in 65 patients with severe aplastic anemia. 1980

Antithymocyte globulin combined with cyclosporine A down-regulates T helper 1 cells by modulating T cell immune response cDNA 7 in aplastic anemia. Medical Oncology 32(7): 197-197, 2016

Immune mediated bone marrow failure in aplastic anemia and myelodysplasia. Leukemia Research 25(Supplement 1): S11, June, 2001

Immunological mechanisms in aplastic anemia. III. Arguments against the role of primary immunologic disorders in aplastic anemia: effect of transfusion of blood components on the course of aplastic anemia. Przeglad Lekarski 39(12): 821-823, 1982

NOTCH signaling in immune-mediated bone marrow failure of aplastic anemia. Rare Diseases 1: E26764-E26764, 2013